These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7825684)

  • 1. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.
    Kalina RE; Wells CG
    Am J Ophthalmol; 1995 Jan; 119(1):112-3. PubMed ID: 7825684
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.
    Heier JS; Dragoo RA; Enzenauer RW; Waterhouse WJ
    Am J Ophthalmol; 1994 Jun; 117(6):772-5. PubMed ID: 7880223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectral Domain OCT Imaging Techniques in Tamoxifen Retinopathy.
    Neuville J; Yevseyenkov V
    Optom Vis Sci; 2015 Feb; 92(2):e55-9. PubMed ID: 25525894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity].
    Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P
    J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular toxicity of tamoxifen.
    Gerner EW
    Ann Ophthalmol; 1989 Nov; 21(11):420-3. PubMed ID: 2619152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal changes associated with tamoxifen treatment for breast cancer.
    Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
    Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Risk Factors of Tamoxifen Retinopathy.
    Kim HA; Lee S; Eah KS; Yoon YH
    Ophthalmology; 2020 Apr; 127(4):555-557. PubMed ID: 31813590
    [No Abstract]   [Full Text] [Related]  

  • 8. Crystalline maculopathy: a rare complication of tamoxifen therapy.
    Srikantia N; Mukesh S; Krishnaswamy M
    J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAMOXIFEN RETINOPATHY DURING TREATMENT OF AN INOPERABLE DESMOID TUMOR.
    Furst M; Somogyi MB; Wong RW; Araujo D; Harper CA
    Retin Cases Brief Rep; 2020; 14(3):268-270. PubMed ID: 29227350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen retinopathy: does it really exist?
    Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA
    Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen retinopathy in a male patient.
    Yanyali AC; Freund KB; Sorenson JA; Slakter JS; Wheatley HM
    Am J Ophthalmol; 2001 Mar; 131(3):386-7. PubMed ID: 11239879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term tamoxifen citrate use and potential ocular toxicity.
    Gorin MB; Day R; Costantino JP; Fisher B; Redmond CK; Wickerham L; Gomolin JE; Margolese RG; Mathen MK; Bowman DM; Kaufman DI; Dimitrov NV; Singerman LJ; Bornstein R; Wolmark N
    Am J Ophthalmol; 1998 Apr; 125(4):493-501. PubMed ID: 9559735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen retinopathy.
    McKeown CA; Swartz M; Blom J; Maggiano JM
    Br J Ophthalmol; 1981 Mar; 65(3):177-9. PubMed ID: 7225310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen retinopathy.
    Kaiser-Kupfer MI; Lippman ME
    Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography findings in tamoxifen retinopathy.
    Gualino V; Cohen SY; Delyfer MN; Sahel JA; Gaudric A
    Am J Ophthalmol; 2005 Oct; 140(4):757-8. PubMed ID: 16226541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
    Salomão SR; Watanabe SE; Berezovsky A; Motono M
    Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To stop or not? Tamoxifen therapy for secondary prevention of breast cancer in a patient with ocular toxicity.
    Bommireddy T; Carrim ZI
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tamoxifen retinopathy: a case series of clinical and functional data].
    Ritter C; Renner AB; Wachtlin J; Bechrakis NE; Krause L
    Ophthalmologe; 2008 Jun; 105(6):544-9. PubMed ID: 18415107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen retinopathy. A case report.
    Costa RH; Dhooge MR; Van Wing F; De Rouck AF
    Bull Soc Belge Ophtalmol; 1990; 238():161-8. PubMed ID: 2131119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophysiological studies in breast carcinoma patients with tamoxifen retinopathy].
    Kuchenbecker J; Pump-Schmidt C; Olbricht S; Weise W; Behrens-Baumann W
    Ophthalmologe; 2001 Jan; 98(1):81-5. PubMed ID: 11220276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.